SCHEMBL19918968

SCHEMBL19918968

CCN1CCC(NC(=O)c2cc(OC)c(Nc3ncc(C(F)(F)F)c(OCCc4cccc5c4C(=O)N(C)C5)n3)cc2Cl)CC1

nearest known ligand 0.83

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PTK2 Q05397 20/20 0.83

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19918789 0.94 PTK2 (0.83) PTK2
SCHEMBL12135193 0.91 PTK2 (1.00) PTK2
SCHEMBL19918778 0.90 PTK2 (0.83) PTK2
SCHEMBL12135021 0.85 PTK2 (1.00) PTK2
SCHEMBL12135215 0.84 PTK2 (1.00) PTK2
SCHEMBL19918855 0.82 PTK2 (0.88) PTK2
SCHEMBL12135019 0.81 PTK2 (1.00) PTK2
SCHEMBL12135436 0.80 PTK2 (1.00) PTK2
SCHEMBL25773491 0.80 PTK2 (0.68) PTK2
SCHEMBL25772471 0.80 PTK2 (0.86) PTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2367800-B9 SUBSTITUTED PYRIMIDINES FOR THE TREATMENT OF DISEASES SUCH AS CANCER IPHARMA H K LTD (HK) 2021-10-20 — — EP disclosed
EP-2367800-B1 SUBSTITUTED PYRIMIDINES FOR THE TREATMENT OF DISEASES SUCH AS CANCER BOEHRINGER INGELHEIM INT (DE) 2018-02-28 — — EP disclosed
Send feedback